Bachem (SWX:BANB) Stock Faces Margin Strain As Capex Surges

Bachem Holding walked into this earnings season with a growth-stock label and a rich P/E of 37.6x, yet the share price has drifted down about 3% over the past month to CHF 74.80. Today's H1 numbers put the spotlight on something less glamorous and more important for you as an investor. The peptide and oligonucleotide specialist is pouring money into capacity, with H1 capital expenditure of CHF 148m and EBITDA margin sitting at 25.4%. The key question is whether this heavy build-out and margin squeeze will justify that premium valuation.

Love Bachem Holding's growth profile but uneasy about the heavy capex and pressure on margins? Check out 302 resilient stocks with low risk scores for companies that pair disciplined investment with more resilient risk profiles.

H1 2026 Earnings Summary

• Revenue H1 2026 vs. H1 2025: CHF 326.445m vs. CHF 312.986m (up about 4.3%)
• Net Income H1 2026 vs. H1 2025: CHF 50.27m vs. CHF 50.101m (broadly stable, up about 0.3%)
• Basic EPS H1 2026 vs. H1 2025: CHF 0.67 vs. CHF 0.67 (flat year on year)
• EBITDA Margin H1 2026 vs. prior year H1: 25.4%, with the prior year H1 higher by about 3.7 percentage points (margin diluted by roughly 370 basis points)

Prefer clear visuals over another wall of earnings tables and margin figures? Get a full picture of Bachem Holding with an at-a-glance valuation breakdown in the company report for Bachem Holding.

Bachem Bull Story Relies On Execution Milestones

The bullish story around Bachem centers on heavy capacity expansion converting into faster growth and better margins as new sites ramp and efficiency gains feed through. H1 2026 shows that foundation being laid but not yet fully paying off. Revenue in local currency grew faster than reported sales, helped by CMC Development, and Building K has started producing GMP material, which is a key operational milestone for the capacity-led thesis.

However, EBITDA margin is 25.4%, about 3.7 percentage points lower than the prior year period, so the promised efficiency and automation benefits are not yet visible in reported profitability. Management still guides to a low 30s margin for 2026 and expects a stronger H2 as Building K contributes more Commercial API, which directly tests the claim of rapid ramp-up. For now, Bachem is clearly investing for the bull case but has only partially evidenced the hoped-for earnings inflection.

Compare Bachem Holding's capacity ramp and margin targets with what institutions are actually pricing in. See the consensus price target analysis for Bachem Holding to check how current analyst targets compare with this bullish execution story.

Bear Case on Bachem Capacity Looks Partly Vindicated

The bearish view on Bachem Holding argues that heavy capex, rising competition and tougher pricing could leave the company with underutilized assets and pressured margins. H1 2026 gives this concern some traction. EBITDA margin compressed by about 370 basis points while capex ran at CHF 148m, roughly 45% of sales. This points to meaningful cost absorption before the new capacity is fully earning its keep. Commercial API volumes were lower than H1 2025 and management again points to a stronger H2, so the timing risk that bears highlight has not yet cleared.

At the same time, customer prepayments of CHF 86.2m, a signed anchor customer for Sisslerfeld and solid local currency revenue growth argue against a simple overbuild story. The real issue is not demand existence but pace. On this print, milestones on margin recovery and capacity utilization look pushed to the right rather than disproving the cautious view.

After a period of volatile trading and heavy capex with delayed margin progress, it is fair to ask whether Bachem Holding is showing early symptoms of deeper balance sheet or execution strain. Review our independent risk analysis for Bachem Holding which shows 1 important warning sign

Stay Ahead With Simply Wall St

If Bachem Holding's heavy capex plans and margin pressure have your attention, register for free with Simply Wall St and add it to a Watchlist to track the share price against fair value and watch how the story develops. Once you have taken a position, use the Portfolio Command Center to cut through market noise and focus on the key updates that matter to your holdings. For a broader view, tap into crowd insights and different angles on Bachem Holding and its peers through the Community. By spotting potential catalysts and risks early, you put yourself in a better position to act before the market catches up.

Seeking Alternatives Before The Crowd Does

Markets move fast and the next breakout stock can start flying while you are still focused on Bachem Holding. Scan fresh ideas that are under the radar for now and consider them early.

• Spot cash rich compounders before momentum chasers arrive by reviewing the curated 258 high quality undervalued stocks that may still be priced as if nothing has changed.
• Track potential infrastructure winners as demand for smarter grids builds and institutions are still slow to react with the targeted 35 power grid technology and infrastructure stocks.
• Zero in on automation leaders that could benefit from rising productivity pressure using the hand picked 35 robotics and automation stocks while these opportunities are still being quietly accumulated.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com